BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 6457735)

  • 1. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of 99Tcm-MDP in lung metastasis from osteosarcoma: clinical and animal studies.
    Tsuji T; Yamamuro T; Kotoura Y; Matsumoto M; Tanaka H; Tanaka C; Toguchida J; Endo K; Sakahara H; Koizumi M
    Nucl Med Commun; 1988 Dec; 9(12):947-54. PubMed ID: 3217065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of 99mTc methylene diphosphonate within synovial fluid in osteosarcoma.
    Sandler MS; Heyman S; Watts H
    AJR Am J Roentgenol; 1984 Aug; 143(2):349-50. PubMed ID: 6234787
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of a brain metastasis from osteosarcoma with 99mTc-methylene diphosphonate bone scanning.
    Ozarda AT; Legaspi JR; Haynie TP
    Eur J Nucl Med; 1983; 8(12):552-4. PubMed ID: 6230234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and localization of 99mTc-methylene diphosphonate in mouse osteosarcoma.
    Nakashima H; Ochi H; Yasui N; Hamada H; Ono K
    Eur J Nucl Med; 1982; 7(12):531-5. PubMed ID: 6218993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
    Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
    Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
    Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
    J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scintigraphic appearance of uncommon soft-tissue osteogenic sarcoma metastases.
    Arrington ER; Eisenberg B; Orrison WW; Williamson MR
    J Nucl Med; 1990 May; 31(5):679-81. PubMed ID: 2341904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma.
    Zissimopoulos A; Zanglis A; Andreopoulos D; Baziotis N
    Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma].
    Knop J; Stritzke P; Montz R; Delling G; Winkler K
    Nuklearmedizin; 1985 Apr; 24(2):75-81. PubMed ID: 2410864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns.
    Chew FS; Hudson TM
    AJR Am J Roentgenol; 1982 Jul; 139(1):49-54. PubMed ID: 6283871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A phosphine-substituted diphosphonic acid (HMPD) for improved scintigraphic detection of bone lesions].
    Steinsträsser A; Schwarz A; Alexander C; Berberich R; Zimmer M
    Nuklearmedizin; 1992 Oct; 31(5):164-71. PubMed ID: 1465353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse allergic reaction to technetium-99m methylene diphosphonate.
    Spicer JA; Preston DF; Stephens RL
    J Nucl Med; 1985 Apr; 26(4):373-4. PubMed ID: 2984362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumors.
    Van Laere K; Casier K; Uyttendaele D; Mondelaers W; De Sadeleer C; Simons M; Dierckx R
    J Nucl Med; 1998 Sep; 39(9):1563-9. PubMed ID: 9744344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide detection of primary pulmonary osteogenic sarcoma: a case report and review of the literature.
    Petersen M
    J Nucl Med; 1990 Jun; 31(6):1110-4. PubMed ID: 2189964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary tumor-embolism from intravascular osteosarcoma demonstrated by bone scintigraphy.
    Hoefnagel CA; Marcuse HR; Somers R
    Clin Nucl Med; 1982 Dec; 7(12):574-6. PubMed ID: 6217015
    [No Abstract]   [Full Text] [Related]  

  • 18. Scintigraphy with 99mTc-phosphonate and 67gallium in patients suspected of primary bone tumors.
    Edeling CJ
    Nuklearmedizin; 1982 Aug; 21(4):136-9. PubMed ID: 6959075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
    Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
    Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone scan appearance in aggressive osteogenic sarcoma with pleural, lung, bone, and soft-tissue metastases.
    Othman S; El-Desouki M
    Clin Nucl Med; 2003 Nov; 28(11):926. PubMed ID: 14578712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.